{
  "ticker": "BMY",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T11:58:43.759656",
  "count": 8,
  "transactions": [
    {
      "id": 20450,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-20",
      "transaction_shares": "25000",
      "transaction_price": "69.71",
      "transaction_type": "S",
      "shares_after_transaction": "476104.333"
    },
    {
      "id": 20445,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-15",
      "transaction_shares": "50000",
      "transaction_price": "71.84",
      "transaction_type": "S",
      "shares_after_transaction": "501104.333"
    },
    {
      "id": 20459,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Powell Ann",
      "reporting_owner_cik": "0001570844",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2022-09-14",
      "transaction_shares": "25000",
      "transaction_price": "70.75",
      "transaction_type": "S",
      "shares_after_transaction": "50476.088"
    },
    {
      "id": 20468,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2022-09-13",
      "transaction_shares": "30000",
      "transaction_price": "71.35",
      "transaction_type": "S",
      "shares_after_transaction": "100460"
    },
    {
      "id": 7264,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2022-07-01",
      "transaction_shares": "9356",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "26078"
    },
    {
      "id": 7269,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Weese Michelle",
      "reporting_owner_cik": "0001867715",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1885",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "1885"
    },
    {
      "id": 20452,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2022-07-01",
      "transaction_shares": "9356",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "26078"
    },
    {
      "id": 20461,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Weese Michelle",
      "reporting_owner_cik": "0001867715",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1885",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "1885"
    }
  ]
}